Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 99-104

  Otori, K ^a,b   Sugiyama, K ^a   Fukushima, S ^b   Esumi, H ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Aberrant crypt foci; Colorectal carcinogenesis; Colorectal tumor; Cyclin D1

Indexed keywords

AZOXYMETHANE; BROXURIDINE; CYCLIN D1;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CELL CYCLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANIMALS; AZOXYMETHANE; BROMODEOXYURIDINE; CELL DIVISION; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYCLIN D1; CYTOPLASM; GENE EXPRESSION; HYPERPLASIA; INTESTINAL MUCOSA; MALE; RATS; RATS, INBRED F344; TIME FACTORS;

EID: 0033010317     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00058-0     Document Type: Article

References (29)

1. Motokura T., Arnold A. Cyclins and oncogenesis. Biochim. Biophys. Acta. 1155:1993;63-78.
2. Matsushima H., Roussel M.F., Ashmun E.A., Sherr C. Colony-stimulating factor 1 regulates novel cyclins during the Gi phase of the cell cycle. Cell. 65:1991;701-713.
3. Jiang W., Kahn S.M., Zhou P., Zhang Y.J., Cacace A.M., Infante A.S., Doi S., Santella R.M., Weinstein I.B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene. 8:1993;3447-3457.
4. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
5. Jiang W., Zhang Y.J., Kahn S.M., Hollstein M.C., Santella R.M., Lu S.H., Harris C.C., Montesano R., Weinstein I.B. Altered expression of the cyclin D1 and retinoblastoma gene in human esophageal cancer. Proc Natl. Acad. Sci. USA. 90:1993;9026-9030.
6. Leach F.S., Elledge S.J., Sherr C.J., Willson L.K.V., Markowitz S., Kinzler K.W., Vogelstein B. Amplification of cyclin gene in colorectal carcinomas. Cancer Res. 53:1993;1986-1989.
7. Bartkova J., Lukas J., Atrauss M., Bartek J. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinoma. Int. J. Cancer. 58:1994;568-573.
8. Callender T., El-Naggar A., Lee M.S., Frankenthaler R., Luna M.A., Batsakis J.G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous call carcinoma. Cancer. 74:1994;152-158.
9. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., Amenomori M., Shibagaki I., Nakao K., Ikenaga M., Ishizaki K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54:1994;3107-3110.
10. Zhang S.Y., Caamano J., Cooper F., Guo X., Klein-Szanto A.J.P. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol. 102:1994;695-698.
11. Bettcher D.C., Heighway J., Hasleton P.S., Altermatt H.J., Ryder W.D.J., Cerny T., Thatcher N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer. 73:1996;294-300.
12. Hung W.C., Chai C.Y., Huang J.S., Chuang L.Y. Expression of cyclin D1 and c-K-ras gene product in human epithelial ovarian tumors. Human Pathol. 27:1996;1324-1328.
13. Nikaido T., Li S.F., Shiozawa T., Fujii S. Coabnormal expression of cyclin D1, p53 protein in human uterine endometrial carcinomas. Cancer. 78:1996;1248-1253.
14. Wang Q.S., Sabourin C.L.K., Wang H., Stoner G.D. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis. 17:1996;1583-1588.
15. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:1987;147-151.
16. Stopera S.A., Murphy L.C., Bird R.P. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis. 13:1992;2081-2085.
17. Stopera S.A., Bird R.P. Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer. Carcinogenesis. 13:1992;573-578.
18. Shivapurkar N., Tang Z., Ferreira A., Nasim S., Garett C., Alabaster O. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors by azoxymethane in Fisher-344 rats on high-risk diet. Carcinogenesis. 15:1994;775-778.
19. Tiwawech D., Hasegawa R., Kurata Y., Tatematsu M., Shibata M., Thamavit W., Ito N. Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats. Carcinogenesis. 12:1991;985-990.
20. Wang T., Cardiff R., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369:1994;669-671.
21. Arber N., Hibshoosh H., Moss S.F., Sutter T., Zhang Y., Begg M., Wang S., Weinstein B., Holt P.R. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology. 110:1996;669-674.
22. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA. 91:1994;709-713.
23. Bartkova J., Lukas J., Atrauss M., Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene. 10:1995;775-778.
24. Otori K., Suglyama K., Hasebe T., Fukushima S., Esumi H. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 55:1995;4743-4746.
25. Filmus J., Robles A.I., Shi W., Wong M.J., Colombo L.L., Conti C.J. Induction of cyclin D1 overexpression by activated ras. Oncogene. 9:1994;3627-3633.
26. Lovec H., Sewing A., Lucibello F.C., Möröy R.M.T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene. 9:1994;323-326.
27. Konstantakos A.K., Siu I.M., Pretlow T.G., Stellato T.A., Pretlow T.P. Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology. 111:1996;772-777.
28. Mcintosh G.G., Anderson J.J., Milton I., Steward M., Parr A.H., Thomas M.D., Henry J.A., Angus B., Lennard T.W.J., Home C.H.W. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene. 11:1995;885-891.
29. Naitoh H., Shibata J., Kawaguchi A., Kodama M., Hattori T. Overexpression and localization of cyclin D1 mRNA and in esophageal cancer. Am. J. Pathol. 146:1995;1161-1169.